Viral Surface Glycoproteins, Gp120 and Gp41, as Potential Drug Targets Against Hiv-1: Brief Overview One Quarter of a Century Past the Approval of Zidovudine, the First Anti-Retroviral Drug
AuthID
P-002-SVE
P-002-SVE